FILE PHOTO: Containers are seen in a laboratory in an enzyme factory of Danish biopharmaceutical company Novozymes in Beijing, China May 24, 2011. REUTERS/David Gray/File Photo COPENHAGEN (Reuters) - ...

COPENHAGEN, Oct 7 (Reuters) - When Denmark's Novozymes first wondered in 2000 how its mass-produced enzymes could be used to make advanced biofuel, the industry did not exist and only now is the fruit ...

Novozymes' stock is declining for almost two years and has lost almost 50% of its previous value. The company reported mediocre half-year results for fiscal 2023. But Novozymes has a wide economic ...

The merger, announced in a joint statement Monday, will see the dissolution of Chr. Hansen and is expected to complete in the fourth quarter of 2023. The new group will have annual revenues of ...

Novozymes is increasing prices to counter soft demand and high costs, but end markets probably won't tolerate rising prices indefinitely. With generally weak input price inflation, Novozymes' stock ...

Fracking presents no risk to Novozymes ' bioenergy business, the biotechnology firm's chief financial officer told CNBC on Thursday, after it beat first-quarter profit expectations. Although 17 ...

Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are wondering whether Novozymes at a last close of ...

Novozymes (CPSE:NSIS B) might not be grabbing headlines with earth-shaking news right now, but that doesn’t mean investors should overlook what’s happening under the surface. Even modest moves can ...

As a result of its actions to reduce carbon emissions and mitigate the business risks of climate change, Novozymes has been awarded with a position on the A List: The CDP Climate Performance ...

COPENHAGEN, April 11 (Reuters) - Danish enzymes maker Novozymes has invested in a new lab in Turkey to develop baking enzymes that help to prevent flatbreads traditionally eaten across the Middle East ...

Novozymes, the world's largest manufacturer of industrial enzymes, has made a gift of $500,000 to the UC Davis Foundation to support an endowed chair devoted to the director of the UC Davis Genome ...